In the preliminary findings of a study conducted with the National Taiwan University Hospital, over 50% of sample cases were reclassified as HER2-expressing when 3D pathology was applied. HSINCHU, April 16, 2025 /PRNewswire/ -- JelloX Biotech Inc., a Taiwan-based startup at the forefront...
Read More Details
Finally We wish PressBee provided you with enough information of ( Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration )
Also on site :
- RHOM star Larsa Pippen got ‘boob job, nose job, BBL and fillers’ to look like a ‘doll,’ top plastic surgeon claims
- Beloved '90s Actress, 53, Goes Makeup Free in Rare Summer Photos With Husband: 'Make the Time'
- Coco Gauff and Aryna Sabalenka dance at Centre Court and post about it on TikTok and Instagram